|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01358 PW MEDTECH
Nominal 
1.030 0.000 (0.000%) | 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Turnover | 675,084 | 25.755% | 536,826 | 271,399 | 247,352 | 362,183 |
| Cost of Sales | (294,187) | 23.607% | (238,001) | (105,343) | (98,748) | (140,056) |
| Gross Profit | 380,897 | 27.465% | 298,825 | 166,056 | 148,604 | 222,127 |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | (61) | -75.600% | (250) | (52,591) | (1,753) | (1,650) | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | (6,100) | -- | -- | 731,750 | 587,715 | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 113,410 | 112,821 | |
| Profit / (Loss) before Taxation | 231,067 | 46.479% | 157,747 | 737,464 | 626,599 | 85,808 | |
| Taxation | (26,044) | -9.820% | (28,880) | 1,653 | 5,212 | (3,839) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (51,839) | 127.105% | (22,826) | 3 | 3 | 13 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 153,184 | 44.457% | 106,041 | 739,120 | 631,814 | 81,982 | |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (43,671) | 25.117% | (34,904) | (56,730) | 5,126 | 28,684 |
| Depreciation & Amortisation | 98,261 | 25.036% | 78,586 | 31,415 | 28,435 | 29,403 |
| Directors' Emoluments | 2,205 | 3.667% | 2,127 | 3,861 | 2,164 | 2,562 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | 9.780 | 44.461% | 6.770 | 47.100 | 40.260 | 5.220 |
| DPS (cts) | 8.933 | -- | 0.000 | 0.000 | 133.013 | 0.000 |
| Dividend Payout Ratio (%) | 91.336% | -- | -- | -- | 330.384% | -- |
| Cash flow per share ($) | 0.135 | -- | 0.172 | 0.024 | 0.050 | 0.064 |
| NBV per share ($) | 2.583 | -- | 2.520 | 2.417 | 3.255 | 2.937 |
| Remarks: | Real time quote last updated: 25/11/2024 08:26 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 70,219,000 |
| %Change | -1.067% |
| EPS / (LPS) | RMB 0.045 |
| NBV Per Share (¥) | RMB 2.580 |